Protein lipid modifications-More than just a greasy ballast

Proteomics

Volumn 16, Issue 5, 2016, Pages 759-782

  Hentschel, Andreas ^a   Zahedi, René P ^a   Ahrends, Robert ^a  

^a LEIBNIZ INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN ISAS E V   (Germany)

Author keywords

Acylation; Cell biology; Cholesterylation; Electrophiles; Lipidation; Prenylation

Indexed keywords

4 HYDROXYNONENAL; ACID; ACROLEIN; FATTY ACID; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LIPID; LIPID HYDROPEROXIDE; MALONALDEHYDE; OXYSTEROL; PHOSPHOLIPID; PROTEIN; STEROL;

ATHEROSCLEROSIS; ELECTROPHILICITY; HUMAN; LIPID PEROXIDATION; MASS SPECTROMETRY; MYRISTYLATION; NONHUMAN; OXIDATIVE STRESS; PALMITOYLATION; PHYSICAL CHEMISTRY; PRENYLATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; RADIOACTIVITY; REVIEW; CHEMISTRY; LIPID METABOLISM; LIPOYLATION; METABOLISM; PHYSIOLOGY; PROTEIN PRENYLATION;

HUMANS; LIPID METABOLISM; LIPIDS; LIPOYLATION; PROTEIN PRENYLATION; PROTEINS;

EID: 84959456541     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201500353     Document Type: Review

References (299)

1. Venne, A. S., Solari, F. A., Faden, F., Paretti, T. et al., An improved workflow for quantitative N-terminal charge-based fractional diagonal chromatography (ChaFRADIC) to study proteolytic events in Arabidopsis thaliana. Proteomics 2015, 15, 2458-2469.
2. Pepinsky, R. B., Zeng, C., Wen, D., Rayhorn, P. et al., Identification of a palmitic acid-modified form of human Sonic hedgehog. J. Biol. Chem. 1998, 273, 14037-14045.
3. Tukachinsky, H., Kuzmickas, R. P., Jao, C. Y., Liu, J., Salic, A., Dispatched and scube mediate the efficient secretion of the cholesterol-modified hedgehog ligand. Cell Rep. 2012, 2, 308-320.
4. Peters, C., Wolf, A., Wagner, M., Kuhlmann, J., Waldmann, H., The cholesterol membrane anchor of the Hedgehog protein confers stable membrane association to lipid-modified proteins. Proc. Natl. Acad. Sci. USA 2004, 101, 8531-8536.
5. Chen, Y., Knezevic, V., Ervin, V., Hutson, R. et al., Direct interaction with Hoxd proteins reverses Gli3-repressor function to promote digit formation downstream of Shh. Development 2004, 131, 2339-2347.
6. Rietveld, A., Neutz, S., Simons, K., Eaton, S., Association of sterol- and glycosylphosphatidylinositol-linked proteins with Drosophila raft lipid microdomains. J. Biol. Chem. 1999, 274, 12049-12054.
7. Katanaev, V. L., Solis, G. P., Hausmann, G., Buestorf, S. et al., Reggie-1/flotillin-2 promotes secretion of the long-range signalling forms of Wingless and Hedgehog in Drosophila. EMBO J. 2008, 27, 509-521.
8. Vyas, N., Goswami, D., Manonmani, A., Sharma, P. et al., Nanoscale organization of hedgehog is essential for long-range signaling. Cell 2008, 133, 1214-1227.
9. Cabrera-Vera, T. M., Vanhauwe, J., Thomas, T. O., Medkova, M. et al., Insights into G Protein Structure, Function, and Regulation. Endocr. Rev. 2003, 24, 765-781.
10. Adjobo-Hermans, M. J., Goedhart, J., Gadella, T. W., Jr., Plant G protein heterotrimers require dual lipidation motifs of Galpha and Ggamma and do not dissociate upon activation. J. Cell Sci. 2006, 119, 5087-5097.
11. Clevers, H., Loh, K. M., Nusse, R., Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. Science 2014, 346, 1248012.
12. Schmidt, M. F., Bracha, M., Schlesinger, M. J., Evidence for covalent attachment of fatty acids to Sindbis virus glycoproteins. Proc. Natl. Acad. Sci. USA 1979, 76, 1687-1691.
13. Schlesinger, M. J., Magee, A. I., Schmidt, M. F., Fatty acid acylation of proteins in cultured cells. J. Biol. Chem. 1980, 255, 10021-10024.
14. Drisdel, R. C., Green, W. N., Labeling and quantifying sites of protein palmitoylation. Biotechniques 2004, 36, 276-285.
15. Giang, D. K., Cravatt, B. F., A second mammalian N-myristoyltransferase. J. Biol. Chem. 1998, 273, 6595-6598.
16. Manne, V., Roberts, D., Tobin, A., O'Rourke, E. et al., Identification and preliminary characterization of protein-cysteine farnesyltransferase. Proc. Natl. Acad. Sci. USA 1990, 87, 7541-7545.
17. Zhang, F. L., Casey, P. J., Protein prenylation: molecular mechanisms and functional consequences. Annu. Rev. Biochem. 1996, 65, 241-269.
18. Resh, M. D., Trafficking and signaling by fatty-acylated and prenylated proteins. Nat. Chem. Biol. 2006, 2, 584-590.
19. Resh, M. D., Palmitoylation of ligands, receptors, and intracellular signaling molecules. Sci. STKE 2006, 2006, re14.
20. Smotrys, J. E., Linder, M. E., Palmitoylation of intracellular signaling proteins: regulation and function. Annu. Rev. Biochem. 2004, 73, 559-587.
21. Rocks, O., Peyker, A., Kahms, M., Verveer, P. J. et al., An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 2005, 307, 1746-1752.
22. Kanaani, J., Patterson, G., Schaufele, F., Lippincott-Schwartz, J., Baekkeskov, S., A palmitoylation cycle dynamically regulates partitioning of the GABA-synthesizing enzyme GAD65 between ER-Golgi and post-Golgi membranes. J. Cell Sci. 2008, 121, 437-449.
23. Salaun, C., Greaves, J., Chamberlain, L. H., The intracellular dynamic of protein palmitoylation. J. Cell Biol. 2010, 191, 1229-1238.
24. Aicart-Ramos, C., Valero, R. A., Rodriguez-Crespo, I., Protein palmitoylation and subcellular trafficking. Biochim. Biophys. Acta 2011, 1808, 2981-2994.
25. Martin, B. R., Wang, C., Adibekian, A., Tully, S. E., Cravatt, B. F., Global profiling of dynamic protein palmitoylation. Nat. Methods 2012, 9, 84-89.
26. Tate, E. W., Kalesh, K. A., Lanyon-Hogg, T., Storck, E. M., Thinon, E., Global profiling of protein lipidation using chemical proteomic technologies. Curr. Opin. Chem. Biol. 2015, 24, 48-57.
27. Lobo, S., Greentree, W. K., Linder, M. E., Deschenes, R. J., Identification of a Ras palmitoyltransferase in Saccharomyces cerevisiae. J. Biol. Chem. 2002, 277, 41268-41273.
28. Zeidman, R., Jackson, C. S., Magee, A. I., Protein acyl thioesterases (Review). Mol. Membr. Biol. 2009, 26, 32-41.
29. Tomatis, V. M., Trenchi, A., Gomez, G. A., Daniotti, J. L., Acyl-protein thioesterase 2 catalyzes the deacylation of peripheral membrane-associated GAP-43. PloS One 2010, 5, e15045.
30. David A. Mitchell, Anant Vasudevan, Maurine E. Linder, Deschenes, a. R. J., Thematic review series: Lipid Posttranslational Modifications. Protein palmitoylation by a family of DHHC protein S-acyltransferases. J. Lipid Res. 2006, 47, 1118-1127.
31. Conibear, E., Davis, N. G., Palmitoylation and depalmitoylation dynamics at a glance. J. Cell Sci. 2010, 123, 4007-4010.
32. Ohno, Y., Kihara, A., Sano, T., Igarashi, Y., Intracellular localization and tissue-specific distribution of human and yeast DHHC cysteine-rich domain-containing proteins. Biochim. Biophys. Acta 2006, 1761, 474-483.
33. Fukata, M., Fukata, Y., Adesnik, H., Nicoll, R. A., Bredt, D. S., Identification of PSD-95 palmitoylating enzymes. Neuron 2004, 44, 987-996.
34. Buglino, J. A., Resh, M. D., Hhat is a palmitoylacyltransferase with specificity for N-palmitoylation of Sonic Hedgehog. J. Biol. Chem. 2008, 283, 22076-22088.
35. Hofmann, K., A superfamily of membrane-bound O-acyltransferases with implications for wnt signaling. Trends Biochem. Sci. 2000, 25, 111-112.
36. Duncan, J. A., Gilman, A. G., Autoacylation of G protein alpha subunits. J. Biol. Chem. 1996, 271, 23594-23600.
37. Faergeman, N. J., Knudsen, J., Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. Biochem. J. 1997, 323(Pt 1), 1-12.
38. Leventis, R., Juel, G., Knudsen, J. K., Silvius, J. R., Acyl-CoA binding proteins inhibit the nonenzymic S-acylation of cysteinyl-containing peptide sequences by long-chain acyl-CoAs. Biochemistry 1997, 36, 5546-5553.
39. Dunphy, J. T., Schroeder, H., Leventis, R., Greentree, W. K. et al., Differential effects of acyl-CoA binding protein on enzymatic and non-enzymatic thioacylation of protein and peptide substrates. Biochim. Biophys. Acta 2000, 1485, 185-198.
40. Wolven, A., Okamura, H., Rosenblatt, Y., Resh, M. D., Palmitoylation of p59fyn is reversible and sufficient for plasma membrane association. Mol. Biol. Cell 1997, 8, 1159-1173.
41. Alland, L., Peseckis, S. M., Atherton, R. E., Berthiaume, L., Resh, M. D., Dual myristylation and palmitylation of Src family member p59fyn affects subcellular localization. J. Biol. Chem. 1994, 269, 16701-16705.
42. Shahinian, S., Silvius, J. R., Doubly-lipid-modified protein sequence motifs exhibit long-lived anchorage to lipid bilayer membranes. Biochemistry 1995, 34, 3813-3822.
43. Dunphy, J. T., Greentree, W. K., Manahan, C. L., Linder, M. E., G-protein palmitoyltransferase activity is enriched in plasma membranes. J. Biol. Chem. 1996, 271, 7154-7159.
44. Cadwallader, K. A., Paterson, H., Macdonald, S. G., Hancock, J. F., N-terminally myristoylated Ras proteins require palmitoylation or a polybasic domain for plasma membrane localization. Mol. Cell. Biol. 1994, 14, 4722-4730.
45. Blaskovic, S., Blanc, M., van der Goot, F. G., What does S-palmitoylation do to membrane proteins? FEBS J. 2013, 280, 2766-2774.
46. Gao, Z., Ni, Y., Szabo, G., Linden, J., Palmitoylation of the recombinant human A1 adenosine receptor: enhanced proteolysis of palmitoylation-deficient mutant receptors. Biochem. J. 1999, 342(Pt 2), 387-395.
47. Percherancier, Y., Planchenault, T., Valenzuela-Fernandez, A., Virelizier, J. L. et al., Palmitoylation-dependent control of degradation, life span, and membrane expression of the CCR5 receptor. J. Biol. Chem. 2001, 276, 31936-31944.
48. Ochsenbauer-Jambor, C., Miller, D. C., Roberts, C. R., Rhee, S. S., Hunter, E., Palmitoylation of the Rous sarcoma virus transmembrane glycoprotein is required for protein stability and virus infectivity. J. Virol. 2001, 75, 11544-11554.
49. Valdez-Taubas, J., Pelham, H., Swf1-dependent palmitoylation of the SNARE Tlg1 prevents its ubiquitination and degradation. EMBO J. 2005, 24, 2524-2532.
50. Abrami, L., Leppla, S. H., van der Goot, F. G., Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis. J. Cell Biol. 2006, 172, 309-320.
51. Tanimura, N., Saitoh, S., Kawano, S., Kosugi, A., Miyake, K., Palmitoylation of LAT contributes to its subcellular localization and stability. Biochem. Biophys. Res. Commun. 2006, 341, 1177-1183.
52. Hach, J. C., McMichael, T., Chesarino, N. M., Yount, J. S., Palmitoylation on conserved and nonconserved cysteines of murine IFITM1 regulates its stability and anti-influenza A virus activity. J. Virol. 2013, 87, 9923-9927.
53. Rossin, A., Durivault, J., Chakhtoura-Feghali, T., Lounnas, N. et al., Fas palmitoylation by the palmitoyl acyltransferase DHHC7 regulates Fas stability. Cell Death Differ. 2015, 22, 643-653.
54. Mor, A., Philips, M. R., Compartmentalized Ras/MAPK signaling. Annu. Rev. Immunol. 2006, 24, 771-800.
55. Wright, L. P., Philips, M. R., Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras. J. Lipid Res. 2006, 47, 883-891.
56. Ahearn, I. M., Haigis, K., Bar-Sagi, D., Philips, M. R., Regulating the regulator: post-translational modification of RAS. Nat. Rev. Mol. Cell Biol. 2012, 13, 39-51.
57. Lorentzen, A., Kinkhabwala, A., Rocks, O., Vartak, N., Bastiaens, P. I., Regulation of Ras localization by acylation enables a mode of intracellular signal propagation. Sci. Signal. 2010, 3, ra68.
58. Dekker, F. J., Rocks, O., Vartak, N., Menninger, S. et al., Small-molecule inhibition of APT1 affects Ras localization and signaling. Nat. Chem. Biol. 2010, 6, 449-456.
59. Lynch, S. J., Snitkin, H., Gumper, I., Philips, M. R. et al., The differential palmitoylation states of N-Ras and H-Ras determine their distinct Golgi subcompartment localizations. J. Cell. Physiol. 2015, 230, 610-619.
60. Chiu, V. K., Bivona, T., Hach, A., Sajous, J. B. et al., Ras signalling on the endoplasmic reticulum and the Golgi. Nat. Cell Biol. 2002, 4, 343-350.
61. Lee, J. J., von Kessler, D. P., Parks, S., Beachy, P. A., Secretion and localized transcription suggest a role in positional signaling for products of the segmentation gene hedgehog. Cell 1992, 71, 33-50.
62. Chamoun, Z., Mann, R. K., Nellen, D., von Kessler, D. P. et al., Skinny hedgehog, an acyltransferase required for palmitoylation and activity of the hedgehog signal. Science 2001, 293, 2080-2084.
63. Micchelli, C. A., The, I., Selva, E., Mogila, V., Perrimon, N., Rasp, a putative transmembrane acyltransferase, is required for Hedgehog signaling. Development 2002, 129, 843-851.
64. Porter, J. A., Young, K. E., Beachy, P. A., Cholesterol modification of hedgehog signaling proteins in animal development. Science 1996, 274, 255-259.
65. Chen, M. H., Li, Y. J., Kawakami, T., Xu, S. M., Chuang, P. T., Palmitoylation is required for the production of a soluble multimeric Hedgehog protein complex and long-range signaling in vertebrates. Genes Dev. 2004, 18, 641-659.
66. Ciepla, P., Konitsiotis, A. D., Serwa, R. A., Masumoto, N. et al., New chemical probes targeting cholesterylation of Sonic Hedgehog in human cells and zebrafish. Chem. Sci. 2014, 5, 4249-4259.
67. Lee, J. D., Kraus, P., Gaiano, N., Nery, S. et al., An acylatable residue of Hedgehog is differentially required in Drosophila and mouse limb development. Dev. Biol. 2001, 233, 122-136.
68. Ingham, P. W., McMahon, A. P., Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001, 15, 3059-3087.
69. Varjosalo, M., Taipale, J., Hedgehog: functions and mechanisms. Genes Dev. 2008, 22, 2454-2472.
70. Carr, S. A., Biemann, K., Shoji, S., Parmelee, D. C., Titani, K., n-Tetradecanoyl is the NH2-terminal blocking group of the catalytic subunit of cyclic AMP-dependent protein kinase from bovine cardiac muscle. Proc. Natl. Acad. Sci. USA 1982, 79, 6128-6131.
71. Aitken, A., Cohen, P., Santikarn, S., Williams, D. H. et al., Identification of the NH2-terminal blocking group of calcineurin B as myristic acid. FEBS Lett. 1982, 150, 314-318.
72. Ozols, J., Korza, G., Heinemann, F. S., Hediger, M. A., Strittmatter, P., Complete amino acid sequence of steer liver microsomal NADH-cytochrome b5 reductase. J. Biol. Chem. 1985, 260, 11953-11961.
73. Cross, F. R., Garber, E. A., Pellman, D., Hanafusa, H., A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation. Mol. Cell. Biol. 1984, 4, 1834-1842.
74. Wilcox, C., Hu, J. S., Olson, E. N., Acylation of proteins with myristic acid occurs cotranslationally. Science 1987, 238, 1275-1278.
75. Zha, J., Weiler, S., Oh, K. J., Wei, M. C., Korsmeyer, S. J., Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 2000, 290, 1761-1765.
76. Martin, D. D., Beauchamp, E., Berthiaume, L. G., Post-translational myristoylation: Fat matters in cellular life and death. Biochimie 2011, 93, 18-31.
77. Glover, C. J., Felsted, R. L., Identification and characterization of multiple forms of bovine brain N-myristoyltransferase. J. Biol. Chem. 1995, 270, 23226-23233.
78. Farazi, T. A., Waksman, G., Gordon, J. I., The biology and enzymology of protein N-myristoylation. J. Biol. Chem. 2001, 276, 39501-39504.
79. Towler, D. A., Adams, S. P., Eubanks, S. R., Towery, D. S. et al., Purification and characterization of yeast myristoyl CoA:protein N-myristoyltransferase. Proc. Natl. Acad. Sci. USA 1987, 84, 2708-2712.
80. Rudnick, D. A., McWherter, C. A., Rocque, W. J., Lennon, P. J. et al., Kinetic and structural evidence for a sequential ordered Bi Bi mechanism of catalysis by Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. J. Biol. Chem. 1991, 266, 9732-9739.
81. McLaughlin, S., Aderem, A., The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions. Trends Biochem. Sci. 1995, 20, 272-276.
82. Resh, M. D., Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta 1999, 1451, 1-16.
83. Goldberg, J., Structural basis for activation of ARF GTPase: mechanisms of guanine nucleotide exchange and GTP-myristoyl switching. Cell 1998, 95, 237-248.
84. Ames, J. B., Ishima, R., Tanaka, T., Gordon, J. I. et al., Molecular mechanics of calcium-myristoyl switches. Nature 1997, 389, 198-202.
85. Bryant, M., Ratner, L., Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA 1990, 87, 523-527.
86. Mill, P., Lee, A. W., Fukata, Y., Tsutsumi, R. et al., Palmitoylation regulates epidermal homeostasis and hair follicle differentiation. PLoS genetics 2009, 5, e1000748.
87. Tsutsumi, R., Fukata, Y., Noritake, J., Iwanaga, T. et al., Identification of G protein alpha subunit-palmitoylating enzyme. Mol. Cell. Biol. 2009, 29, 435-447.
88. Thinon, E., Serwa, R. A., Broncel, M., Brannigan, J. A. et al., Global profiling of co- and post-translationally N-myristoylated proteomes in human cells. Nat. Commun. 2014, 5, 4919.
89. Duncan, J. A., Gilman, A. G., A cytoplasmic acyl-protein thioesterase that removes palmitate from G protein alpha subunits and p21(RAS). J. Biol. Chem. 1998, 273, 15830-15837.
90. Yeh, D. C., Duncan, J. A., Yamashita, S., Michel, T., Depalmitoylation of endothelial nitric-oxide synthase by acyl-protein thioesterase 1 is potentiated by Ca(2+)-calmodulin. J. Biol. Chem. 1999, 274, 33148-33154.
91. Camp, L. A., Hofmann, S. L., Purification and properties of a palmitoyl-protein thioesterase that cleaves palmitate from H-Ras. J. Biol. Chem. 1993, 268, 22566-22574.
92. Verkruyse, L. A., Hofmann, S. L., Lysosomal targeting of palmitoyl-protein thioesterase. J. Biol. Chem. 1996, 271, 15831-15836.
93. Camp, L. A., Verkruyse, L. A., Afendis, S. J., Slaughter, C. A., Hofmann, S. L., Molecular cloning and expression of palmitoyl-protein thioesterase. J. Biol. Chem. 1994, 269, 23212-23219.
94. Putilina, T., Wong, P., Gentleman, S., The DHHC domain: a new highly conserved cysteine-rich motif. Mol. Cell. Biochem. 1999, 195, 219-226.
95. Oyama, T., Miyoshi, Y., Koyama, K., Nakagawa, H. et al., Isolation of a novel gene on 8p21.3-22 whose expression is reduced significantly in human colorectal cancers with liver metastasis. Genes Chromosomes Cancer 2000, 29, 9-15.
96. Sharma, C., Yang, X. H., Hemler, M. E., DHHC2 affects palmitoylation, stability, and functions of tetraspanins CD9 and CD151. Mol. Biol. Cell 2008, 19, 3415-3425.
97. Planey, S. L., Keay, S. K., Zhang, C. O., Zacharias, D. A., Palmitoylation of cytoskeleton associated protein 4 by DHHC2 regulates antiproliferative factor-mediated signaling. Mol. Biol. Cell 2009, 20, 1454-1463.
98. Zeidman, R., Buckland, G., Cebecauer, M., Eissmann, P. et al., DHHC2 is a protein S-acyltransferase for Lck. Mol. Membr. Biol. 2011, 28, 473-486.
99. Greaves, J., Gorleku, O. A., Salaun, C., Chamberlain, L. H., Palmitoylation of the SNAP25 protein family: specificity and regulation by DHHC palmitoyl transferases. J. Biol. Chem. 2010, 285, 24629-24638.
100. Uemura, T., Mori, H., Mishina, M., Isolation and characterization of Golgi apparatus-specific GODZ with the DHHC zinc finger domain. Biochem. Biophys. Res. Commun. 2002, 296, 492-496.
101. Keller, C. A., Yuan, X., Panzanelli, P., Martin, M. L. et al., The gamma2 subunit of GABA(A) receptors is a substrate for palmitoylation by GODZ. J. Neurosci. 2004, 24, 5881-5891.
102. Fernandez-Hernando, C., Fukata, M., Bernatchez, P. N., Fukata, Y. et al., Identification of Golgi-localized acyl transferases that palmitoylate and regulate endothelial nitric oxide synthase. J. Cell Biol. 2006, 174, 369-377.
103. Vetrivel, K. S., Meckler, X., Chen, Y., Nguyen, P. D. et al., Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts. J. Biol. Chem. 2009, 284, 3793-3803.
104. Tian, L., McClafferty, H., Jeffries, O., Shipston, M. J., Multiple palmitoyltransferases are required for palmitoylation-dependent regulation of large conductance calcium- and voltage-activated potassium channels. J. Biol. Chem. 2010, 285, 23954-23962.
105. Chen, W. Y., Shi, Y. Y., Zheng, Y. L., Zhao, X. Z. et al., Case-control study and transmission disequilibrium test provide consistent evidence for association between schizophrenia and genetic variation in the 22q11 gene ZDHHC8. Hum. Mol. Genet. 2004, 13, 2991-2995.
106. Yang, W., Di Vizio, D., Kirchner, M., Steen, H., Freeman, M. R., Proteome scale characterization of human S-acylated proteins in lipid raft-enriched and non-raft membranes. Mol. Cell. Proteomics 2010, 9, 54-70.
107. Pedram, A., Razandi, M., Deschenes, R. J., Levin, E. R., DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors. Mol. Biol. Cell 2012, 23, 188-199.
108. Mukai, J., Liu, H., Burt, R. A., Swor, D. E. et al., Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat. Genet. 2004, 36, 725-731.
109. el-Husseini Ael, D., Bredt, D. S., Protein palmitoylation: a regulator of neuronal development and function. Nat. Rev. Neurosci. 2002, 3, 791-802.
110. Otani, K., Ujike, H., Tanaka, Y., Morita, Y. et al., The ZDHHC8 gene did not associate with bipolar disorder or schizophrenia. Neurosci. Lett. 2005, 390, 166-170.
111. Thomas, G. M., Hayashi, T., Chiu, S. L., Chen, C. M., Huganir, R. L., Palmitoylation by DHHC5/8 targets GRIP1 to dendritic endosomes to regulate AMPA-R trafficking. Neuron 2012, 73, 482-496.
112. Swarthout, J. T., Lobo, S., Farh, L., Croke, M. R. et al., DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H- and N-Ras. J. Biol. Chem. 2005, 280, 31141-31148.
113. Mansilla, F., Birkenkamp-Demtroder, K., Kruhoffer, M., Sorensen, F. B. et al., Differential expression of DHHC9 in microsatellite stable and instable human colorectal cancer subgroups. Br. J. Cancer 2007, 96, 1896-1903.
114. Yamamoto, Y., Chochi, Y., Matsuyama, H., Eguchi, S. et al., Gain of 5p15.33 is associated with progression of bladder cancer. Oncology 2007, 72, 132-138.
115. Mizumaru, C., Saito, Y., Ishikawa, T., Yoshida, T. et al., Suppression of APP-containing vesicle trafficking and production of beta-amyloid by AID/DHHC-12 protein. J. Neurochem. 2009, 111, 1213-1224.
116. Singaraja, R. R., Hadano, S., Metzler, M., Givan, S. et al., HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis. Hum. Mol. Genet. 2002, 11, 2815-2828.
117. Goytain, A., Hines, R. M., Quamme, G. A., Huntingtin-interacting proteins, HIP14 and HIP14L, mediate dual functions, palmitoyl acyltransferase and Mg2+ transport. J. Biol. Chem. 2008, 283, 33365-33374.
118. Huang, K., Sanders, S., Singaraja, R., Orban, P. et al., Neuronal palmitoyl acyl transferases exhibit distinct substrate specificity. FASEB J. 2009, 23, 2605-2615.
119. Yu, L., Reader, J. C., Chen, C., Zhao, X. F. et al., Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemia. Leukemia 2011, 25, 367-371.
120. Mansouri, M. R., Marklund, L., Gustavsson, P., Davey, E. et al., Loss of ZDHHC15 expression in a woman with a balanced translocation t(X;15)(q13.3;cen) and severe mental retardation. Eur. J. Hum. Genet. 2005, 13, 970-977.
121. Greaves, J., Salaun, C., Fukata, Y., Fukata, M., Chamberlain, L. H., Palmitoylation and membrane interactions of the neuroprotective chaperone cysteine-string protein. J. Biol. Chem. 2008, 283, 25014-25026.
122. McCormick, P. J., Dumaresq-Doiron, K., Pluviose, A. S., Pichette, V. et al., Palmitoylation controls recycling in lysosomal sorting and trafficking. Traffic 2008, 9, 1984-1997.
123. Li, B., Cong, F., Tan, C. P., Wang, S. X., Goff, S. P., Aph2, a protein with a zf-DHHC motif, interacts with c-Abl and has pro-apoptotic activity. J. Biol. Chem. 2002, 277, 28870-28876.
124. Zhang, F., Di, Y., Li, J., Shi, Y. et al., Molecular cloning and characterization of human Aph2 gene, involved in AP-1 regulation by interaction with JAB1. Biochim. Biophys. Acta 2006, 1759, 514-525.
125. Ducker, C. E., Stettler, E. M., French, K. J., Upson, J. J., Smith, C. D., Huntingtin interacting protein 14 is an oncogenic human protein: palmitoyl acyltransferase. Oncogene 2004, 23, 9230-9237.
126. Greaves, J., Prescott, G. R., Fukata, Y., Fukata, M. et al., The hydrophobic cysteine-rich domain of SNAP25 couples with downstream residues to mediate membrane interactions and recognition by DHHC palmitoyl transferases. Mol. Biol. Cell 2009, 20, 1845-1854.
127. Gao, T., Collins, R. E., Horton, J. R., Zhang, X. et al., The ankyrin repeat domain of Huntingtin interacting protein 14 contains a surface aromatic cage, a potential site for methyl-lysine binding. Proteins 2009, 76, 772-777.
128. Greaves, J., Chamberlain, L. H., DHHC palmitoyl transferases: substrate interactions and (patho)physiology. Trends Biochem. Sci. 2011, 36, 245-253.
129. Baumgart, F., Corral-Escariz, M., Perez-Gil, J., Rodriguez-Crespo, I., Palmitoylation of R-Ras by human DHHC19, a palmitoyl transferase with a CaaX box. Biochim. Biophys. Acta 2010, 1798, 592-604.
130. Draper, J. M., Smith, C. D., DHHC20: a human palmitoyl acyltransferase that causes cellular transformation. Mol. Membr. Biol. 2010, 27, 123-136.
131. Tian, L., McClafferty, H., Knaus, H. G., Ruth, P., Shipston, M. J., Distinct acyl protein transferases and thioesterases control surface expression of calcium-activated potassium channels. J. Biol. Chem. 2012, 287, 14718-14725.
132. Saitoh, F., Tian, Q. B., Okano, A., Sakagami, H. et al., NIDD, a novel DHHC-containing protein, targets neuronal nitric-oxide synthase (nNOS) to the synaptic membrane through a PDZ-dependent interaction and regulates nNOS activity. J. Biol. Chem. 2004, 279, 29461-29468.
133. Miura, G. I., Buglino, J., Alvarado, D., Lemmon, M. A. et al., Palmitoylation of the EGFR ligand Spitz by Rasp increases Spitz activity by restricting its diffusion. Dev. Cell 2006, 10, 167-176.
134. Kadowaki, T., Wilder, E., Klingensmith, J., Zachary, K., Perrimon, N., The segment polarity gene porcupine encodes a putative multitransmembrane protein involved in Wingless processing. Genes Dev. 1996, 10, 3116-3128.
135. Gao, X., Hannoush, R. N., Single-cell imaging of Wnt palmitoylation by the acyltransferase porcupine. Nat. Chem. Biol. 2014, 10, 61-68.
136. Givan, S. A., Sprague, G. F., Jr., The ankyrin repeat-containing protein Akr1p is required for the endocytosis of yeast pheromone receptors. Mol. Biol. Cell 1997, 8, 1317-1327.
137. Babu, P., Deschenes, R. J., Robinson, L. C., Akr1p-dependent palmitoylation of Yck2p yeast casein kinase 1 is necessary and sufficient for plasma membrane targeting. J Biol Chem 2004, 279, 27138-27147.
138. Smotrys, J. E., Schoenfish, M. J., Stutz, M. A., Linder, M. E., The vacuolar DHHC-CRD protein Pfa3p is a protein acyltransferase for Vac8p. J Cell Biol 2005, 170, 1091-1099.
139. Zhao, L., Lobo, S., Dong, X., Ault, A. D., Deschenes, R. J., Erf4p and Erf2p form an endoplasmic reticulum-associated complex involved in the plasma membrane localization of yeast Ras proteins. J Biol Chem 2002, 277, 49352-49359.
140. Glover, C. J., Goddard, C., Felsted, R. L., N-myristoylation of p60src. Identification of a myristoyl-CoA:glycylpeptide N-myristoyltransferase in rat tissues. Biochem. J. 1988, 250, 485-491.
141. Raju, R. V., Magnuson, B. A., Sharma, R. K., Mammalian myristoyl CoA: protein N-myristoyltransferase. Mol. Cell. Biochem. 1995, 149-150, 191-202.
142. Braam, B., Verhaar, M. C., Understanding eNOS for pharmacological modulation of endothelial function: a translational view. Curr. Pharm. Des. 2007, 13, 1727-1740.
143. London, N., Lamphear, C. L., Hougland, J. L., Fierke, C. A., Schueler-Furman, O., Identification of a novel class of farnesylation targets by structure-based modeling of binding specificity. PLoS Comput. Biol. 2011, 7, e1002170.
144. Lane, K. T., Beese, L. S., Thematic review series: lipid posttranslational modifications. Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I. J. Lipid Res. 2006, 47, 681-699.
145. Wilson, A. L., Erdman, R. A., Castellano, F., Maltese, W. A., Prenylation of Rab8 GTPase by type I and type II geranylgeranyl transferases. Biochem. J. 1998, 333(Pt 3), 497-504.
146. Casey, P. J., Seabra, M. C., Protein prenyltransferases. J. Biol. Chem. 1996, 271, 5289-5292.
147. Kamiya, Y., Sakurai, A., Tamura, S., Takahashi, N., Structure of rhodotorucine A, a novel lipopeptide, inducing mating tube formation in Rhodosporidium toruloides. Biochem. Biophys. Res. Commun. 1978, 83, 1077-1083.
148. Wolda, S. L., Glomset, J. A., Evidence for modification of lamin B by a product of mevalonic acid. J. Biol. Chem. 1988, 263, 5997-6000.
149. Farnsworth, C. C., Wolda, S. L., Gelb, M. H., Glomset, J. A., Human lamin B contains a farnesylated cysteine residue. J. Biol. Chem. 1989, 264, 20422-20429.
150. Kho, Y., Kim, S. C., Jiang, C., Barma, D. et al., A tagging-via-substrate technology for detection and proteomics of farnesylated proteins. Proc. Natl. Acad. Sci. USA 2004, 101, 12479-12484.
151. Clarke, S., Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Annu. Rev. Biochem. 1992, 61, 355-386.
152. Liu, B., Zhou, Z., Lamin A/C, laminopathies and premature ageing. Histol. Histopathol. 2008, 23, 747-763.
153. Peitzsch, R. M., McLaughlin, S., Binding of acylated peptides and fatty acids to phospholipid vesicles: pertinence to myristoylated proteins. Biochemistry 1993, 32, 10436-10443.
154. Silvius, J. R., l'Heureux, F., Fluorimetric evaluation of the affinities of isoprenylated peptides for lipid bilayers. Biochemistry 1994, 33, 3014-3022.
155. Huster, D., Vogel, A., Katzka, C., Scheidt, H. A. et al., Membrane insertion of a lipidated ras peptide studied by FTIR, solid-state NMR, and neutron diffraction spectroscopy. J. Am. Chem. Soc. 2003, 125, 4070-4079.
156. Jackson, J. H., Cochrane, C. G., Bourne, J. R., Solski, P. A. et al., Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. Proc. Natl. Acad. Sci. USA 1990, 87, 3042-3046.
157. Seabra, M. C., Membrane association and targeting of prenylated Ras-like GTPases. Cell. Signal. 1998, 10, 167-172.
158. Mijimolle, N., Velasco, J., Dubus, P., Guerra, C. et al., Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development. Cancer Cell 2005, 7, 313-324.
159. O'Dwyer PJ, G. M., Nguyen B, Waddell MJ, Chiorean EG., Phase I accelerated dose-escalating safety and pharmacokinetic (PK) study of GGTI-2418, a novel geranylgeranyltransferase I inhibitor in patients with refractory solid tumors. Ann. Oncol. 2010, 21.
160. Raponi, M., Harousseau, J. L., Lancet, J. E., Lowenberg, B. et al., Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia. Clin. Cancer Res. 2007, 13, 2254-2260.
161. Harousseau, J. L., Martinelli, G., Jedrzejczak, W. W., Brandwein, J. M. et al., A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older. Blood 2009, 114, 1166-1173.
162. Ding, H., McDonald, J. S., Yun, S., Schneider, P. A. et al., Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells. Haematologica 2014, 99, 60-69.
163. Barrington, R. E., Subler, M. A., Rands, E., Omer, C. A. et al., A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis. Mol. Cell. Biol. 1998, 18, 85-92.
164. Jiang, K., Coppola, D., Crespo, N. C., Nicosia, S. V. et al., The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis. Mol. Cell. Biol. 2000, 20, 139-148.
165. Han, J. Y., Oh, S. H., Morgillo, F., Myers, J. N. et al., Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer. J. Natl. Cancer Inst. 2005, 97, 1272-1286.
166. Delmas, C., End, D., Rochaix, P., Favre, G. et al., The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft. Clin. Cancer Res. 2003, 9, 6062-6068.
167. Crespo, N. C., Delarue, F., Ohkanda, J., Carrico, D. et al., The farnesyltransferase inhibitor, FTI-2153, inhibits bipolar spindle formation during mitosis independently of transformation and Ras and p53 mutation status. Cell Death Differ. 2002, 9, 702-709.
168. Hussein, D., Taylor, S. S., Farnesylation of Cenp-F is required for G2/M progression and degradation after mitosis. J. Cell Sci. 2002, 115, 3403-3414.
169. Sepp-Lorenzino, L., Rosen, N., A farnesyl-protein transferase inhibitor induces p21 expression and G1 block in p53 wild type tumor cells. J. Biol. Chem. 1998, 273, 20243-20251.
170. Porter, J. A., von Kessler, D. P., Ekker, S. C., Young, K. E. et al., The product of hedgehog autoproteolytic cleavage active in local and long-range signalling. Nature 1995, 374, 363-366.
171. Chen, X., Tukachinsky, H., Huang, C. H., Jao, C. et al., Processing and turnover of the Hedgehog protein in the endoplasmic reticulum. J. Cell Biol. 2011, 192, 825-838.
172. Ryan, K. E., Chiang, C., Hedgehog secretion and signal transduction in vertebrates. J. Biol. Chem. 2012, 287, 17905-17913.
173. Miura, G. I., Treisman, J. E., Lipid modification of secreted signaling proteins. Cell Cycle 2006, 5, 1184-1188.
174. Yin, H., Xu, L., Porter, N. A., Free radical lipid peroxidation: mechanisms and analysis. Chem. Rev. 2011, 111, 5944-5972.
175. Forman, H. J., Fukuto, J. M., Miller, T., Zhang, H. et al., The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal. Arch. Biochem. Biophys. 2008, 477, 183-195.
176. Poli, G., Schaur, R. J., Siems, W. G., Leonarduzzi, G., 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med. Res. Rev. 2008, 28, 569-631.
177. Noguchi, N., Role of oxidative stress in adaptive responses in special reference to atherogenesis. J. Clin. Biochem. Nutr. 2008, 43, 131-138.
178. Kanner, J., German, J. B., Kinsella, J. E., Initiation of lipid peroxidation in biological systems. Crit. Rev. Food Sci. Nutr. 1987, 25, 317-364.
179. Esterbauer, H., Cytotoxicity and genotoxicity of lipid-oxidation products. Am. J. Clin. Nutr. 1993, 57, 779S-785S; discussion 785S-786S.
180. Kehrer, J. P., Biswal, S. S., The molecular effects of acrolein. Toxicol. Sci. 2000, 57, 6-15.
181. Niedernhofer, L. J., Daniels, J. S., Rouzer, C. A., Greene, R. E., Marnett, L. J., Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J. Biol. Chem. 2003, 278, 31426-31433.
182. Esterbauer, H., Schaur, R. J., Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11, 81-128.
183. Tsikas, D., Suchy, M. T., Niemann, J., Tossios, P. et al., Glutathione promotes prostaglandin H synthase (cyclooxygenase)-dependent formation of malondialdehyde and 15(S)-8-iso-prostaglandin F2alpha. FEBS Lett. 2012, 586, 3723-3730.
184. Szczeklik, A., Gryglewski, R. J., Grodzinska, L., Musial, J. et al., Platelet aggregability, thromboxane A2 and malonaldehyde formation following administration of aspirin to man. Thromb. Res. 1979, 15, 405-413.
185. Ayala, A., Munoz, M. F., Arguelles, S., Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev. 2014, 2014, 360438.
186. Negre-Salvayre, A., Coatrieux, C., Ingueneau, C., Salvayre, R., Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br. J. Pharmacol. 2008, 153, 6-20.
187. Zarkovic, N., Cipak, A., Jaganjac, M., Borovic, S., Zarkovic, K., Pathophysiological relevance of aldehydic protein modifications. J. Proteomics 2013, 92, 239-247.
188. Wang, X., Lei, X. G., Wang, J., Malondialdehyde regulates glucose-stimulated insulin secretion in murine islets via TCF7L2-dependent Wnt signaling pathway. Mol. Cell. Endocrinol. 2014, 382, 8-16.
189. Garcia-Ruiz, I., de la Torre, P., Diaz, T., Esteban, E. et al., Sp1 and Sp3 transcription factors mediate malondialdehyde-induced collagen alpha 1(I) gene expression in cultured hepatic stellate cells. J. Biol. Chem. 2002, 277, 30551-30558.
190. Uchida, K., Lipofuscin-like fluorophores originated from malondialdehyde. Free Radic. Res. 2006, 40, 1335-1338.
191. Tuma, D. J., Thiele, G. M., Xu, D., Klassen, L. W., Sorrell, M. F., Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology 1996, 23, 872-880.
192. Wang, G., Li, H., Firoze Khan, M., Differential oxidative modification of proteins in MRL+/+ and MRL/lpr mice: Increased formation of lipid peroxidation-derived aldehyde-protein adducts may contribute to accelerated onset of autoimmune response. Free Radic. Res. 2012, 46, 1472-1481.
193. Weismann, D., Binder, C. J., The innate immune response to products of phospholipid peroxidation. Biochim. Biophys. Acta 2012, 1818, 2465-2475.
194. Holvoet, P., Perez, G., Zhao, Z., Brouwers, E. et al., Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. J. Clin. Invest. 1995, 95, 2611-2619.
195. Hill, G. E., Miller, J. A., Baxter, B. T., Klassen, L. W. et al., Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury. Atherosclerosis 1998, 141, 107-116.
196. Duryee, M. J., Klassen, L. W., Schaffert, C. S., Tuma, D. J. et al., Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis. Free Radic. Biol. Med. 2010, 49, 1480-1486.
197. Giera, M., Lingeman, H., Niessen, W. M., Recent Advancements in the LC- and GC-Based Analysis of Malondialdehyde (MDA): A Brief Overview. Chromatographia 2012, 75, 433-440.
198. Jacobs, A. T., Marnett, L. J., Systems analysis of protein modification and cellular responses induced by electrophile stress. Acc. Chem. Res. 2010, 43, 673-683.
199. Blair, I. A., DNA adducts with lipid peroxidation products. J. Biol. Chem. 2008, 283, 15545-15549.
200. Schauenstein E., E. H., Jaag G., Taufer M., The effect of aldehydes on normal and malignant cells. 1st report: hydroxy-octenal, a new fat-aldehyde. Monatshefte Fur Chemie. 1964, 95, 180-183.
201. Berlett, B. S., Stadtman, E. R., Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 1997, 272, 20313-20316.
202. Uchida, K., Szweda, L. I., Chae, H. Z., Stadtman, E. R., Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc. Natl. Acad. Sci. USA 1993, 90, 8742-8746.
203. Schaur, R. J., Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol. Aspects Med. 2003, 24, 149-159.
204. Dalleau, S., Baradat, M., Gueraud, F., Huc, L., Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ. 2013, 20, 1615-1630.
205. Zarkovic, K., 4-hydroxynonenal and neurodegenerative diseases. Mol. Aspects Med. 2003, 24, 293-303.
206. Mattson, M. P., Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp. Gerontol. 2009, 44, 625-633.
207. Karihtala, P., Kauppila, S., Puistola, U., Jukkola-Vuorinen, A., Divergent behaviour of oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis. Histopathology 2011, 58, 854-862.
208. Huang, Y., Li, W., Kong, A. N., Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal. Cell Biosci. 2012, 2, 40.
209. Usatyuk, P. V., Natarajan, V., Role of mitogen-activated protein kinases in 4-hydroxy-2-nonenal-induced actin remodeling and barrier function in endothelial cells. J. Biol. Chem. 2004, 279, 11789-11797.
210. Chen, Z. H., Saito, Y., Yoshida, Y., Sekine, A. et al., 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J. Biol. Chem. 2005, 280, 41921-41927.
211. DeJarnett, N., Conklin, D. J., Riggs, D. W., Myers, J. A. et al., Acrolein exposure is associated with increased cardiovascular disease risk. J. Am. Heart Assoc. 2014, 3.
212. Ghilarducci, D. P., Tjeerdema, R. S., Fate and effects of acrolein. Rev. Environ. Contam. Toxicol. 1995, 144, 95-146.
213. Anderson, M. M., Hazen, S. L., Hsu, F. F., Heinecke, J. W., Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha, beta-unsaturated aldehydes by phagocytes at sites of inflammation. J. Clin. Invest. 1997, 99, 424-432.
214. Tsakadze, N. L., Srivastava, S., Awe, S. O., Adeagbo, A. S. et al., Acrolein-induced vasomotor responses of rat aorta. Am. J. Physiol. Heart Circ. Physiol. 2003, 285, H727-734.
215. Wang, G. W., Guo, Y., Vondriska, T. M., Zhang, J. et al., Acrolein consumption exacerbates myocardial ischemic injury and blocks nitric oxide-induced PKCepsilon signaling and cardioprotection. J. Mol. Cell. Cardiol. 2008, 44, 1016-1022.
216. Conklin, D. J., Bhatnagar, A., Cowley, H. R., Johnson, G. H. et al., Acrolein generation stimulates hypercontraction in isolated human blood vessels. Toxicol. Appl. Pharmacol. 2006, 217, 277-288.
217. Perez, C. M., Ledbetter, A. D., Hazari, M. S., Haykal-Coates, N. et al., Hypoxia stress test reveals exaggerated cardiovascular effects in hypertensive rats after exposure to the air pollutant acrolein. Toxicol. Sci. 2013, 132, 467-477.
218. Srivastava, S., Sithu, S. D., Vladykovskaya, E., Haberzettl, P. et al., Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice. Atherosclerosis 2011, 215, 301-308.
219. Pugazhenthi, S., Phansalkar, K., Audesirk, G., West, A., Cabell, L., Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal. Free Radic. Biol. Med. 2006, 40, 21-34.
220. Volpi, G., Facchinetti, F., Moretto, N., Civelli, M., Patacchini, R., Cigarette smoke and alpha, beta-unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts. Br. J. Pharmacol. 2011, 163, 649-661.
221. Moghe, A., Ghare, S., Lamoreau, B., Mohammad, M. et al., Molecular mechanisms of acrolein toxicity: relevance to human disease. Toxicol. Sci. 2015, 143, 242-255.
222. Gu, X., Zhang, W., Choi, J., Li, W. et al., An (1)O2 route to gamma-hydroxyalkenal phospholipids by vitamin E-induced fragmentation of hydroperoxydiene-derived endoperoxides. Chem. Res. Toxicol. 2011, 24, 1080-1093.
223. Sun, M., Salomon, R. G., Oxidative fragmentation of hydroxy octadecadienoates generates biologically active gamma-hydroxyalkenals. J. Am. Chem. Soc. 2004, 126, 5699-5708.
224. Berliner, J. A., Watson, A. D., A role for oxidized phospholipids in atherosclerosis. N. Engl. J. Med. 2005, 353, 9-11.
225. Spiteller, G., The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis. Mol. Nutr. Food Res. 2005, 49, 999-1013.
226. Gu, X., Sun, M., Gugiu, B., Hazen, S. et al., Oxidatively truncated docosahexaenoate phospholipids: total synthesis, generation, and Peptide adduction chemistry. J. Org. Chem. 2003, 68, 3749-3761.
227. Sun, M., Deng, Y., Batyreva, E., Sha, W., Salomon, R. G., Novel bioactive phospholipids: practical total syntheses of products from the oxidation of arachidonic and linoleic esters of 2-lysophosphatidylcholine(1). J. Org. Chem. 2002, 67, 3575-3584.
228. Podrez, E. A., Poliakov, E., Shen, Z., Zhang, R. et al., A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J. Biol. Chem. 2002, 277, 38517-38523.
229. Podrez, E. A., Poliakov, E., Shen, Z., Zhang, R. et al., Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J. Biol. Chem. 2002, 277, 38503-38516.
230. Podrez, E. A., Byzova, T. V., Febbraio, M., Salomon, R. G. et al., Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat. Med. 2007, 13, 1086-1095.
231. Lee, H., Shi, W., Tontonoz, P., Wang, S. et al., Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ. Res. 2000, 87, 516-521.
232. Watson, A. D., Leitinger, N., Navab, M., Faull, K. F. et al., Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 1997, 272, 13597-13607.
233. Bjorkhem, I., Diczfalusy, U., Oxysterols: friends, foes, or just fellow passengers? Arterioscler. Thromb. Vasc. Biol. 2002, 22, 734-742.
234. Smith, L. L., Johnson, B. H., Biological activities of oxysterols. Free Radic. Biol. Med. 1989, 7, 285-332.
235. Lange, Y., Ye, J., Strebel, F., Movement of 25-hydroxycholesterol from the plasma membrane to the rough endoplasmic reticulum in cultured hepatoma cells. J. Lipid Res. 1995, 36, 1092-1097.
236. Honda, A., Yamashita, K., Hara, T., Ikegami, T. et al., Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. J. Lipid Res. 2009, 50, 350-357.
237. Windsor, K., Genaro-Mattos, T. C., Miyamoto, S., Stec, D. F. et al., Assay of protein and peptide adducts of cholesterol ozonolysis products by hydrophobic and click enrichment methods. Chem. Res. Toxicol. 2014, 27, 1757-1768.
238. Nieva, J., Song, B. D., Rogel, J. K., Kujawara, D. et al., Cholesterol secosterol aldehydes induce amyloidogenesis and dysfunction of wild-type tumor protein p53. Chem. Biol. 2011, 18, 920-927.
239. Stewart, C. R., Wilson, L. M., Zhang, Q., Pham, C. L. et al., Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation. Biochemistry 2007, 46, 5552-5561.
240. Korade, Z., Xu, L., Shelton, R., Porter, N. A., Biological activities of 7-dehydrocholesterol-derived oxysterols: implications for Smith-Lemli-Opitz syndrome. J. Lipid Res. 2010, 51, 3259-3269.
241. Cygan, N. K., Scheinost, J. C., Butters, T. D., Wentworth, P., Jr., Adduction of cholesterol 5, 6-secosterol aldehyde to membrane-bound myelin basic protein exposes an immunodominant epitope. Biochemistry 2011, 50, 2092-2100.
242. Nieva, J., Shafton, A., Altobell, L. J., 3rd, Tripuraneni, S. et al., Lipid-derived aldehydes accelerate light chain amyloid and amorphous aggregation. Biochemistry 2008, 47, 7695-7705.
243. Zhang, Q., Powers, E. T., Nieva, J., Huff, M. E. et al., Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc. Natl. Acad. Sci. USA 2004, 101, 4752-4757.
244. Leonarduzzi, G., Gamba, P., Sottero, B., Kadl, A. et al., Oxysterol-induced up-regulation of MCP-1 expression and synthesis in macrophage cells. Free Radic. Biol. Med. 2005, 39, 1152-1161.
245. Pagel, O., Loroch, S., Sickmann, A., Zahedi, R. P., Current strategies and findings in clinically relevant post-translational modification-specific proteomics. Exp. Rev. Proteomics 2015, 12, 235-253.
246. Houde, V. P., Ritorto, M. S., Gourlay, R., Varghese, J. et al., Investigation of LKB1 Ser431 phosphorylation and Cys433 farnesylation using mouse knockin analysis reveals an unexpected role of prenylation in regulating AMPK activity. Biochem. J. 2014, 458, 41-56.
247. Rush, J., Moritz, A., Lee, K. A., Guo, A. et al., Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 2005, 23, 94-101.
248. Xu, G., Paige, J. S., Jaffrey, S. R., Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat. Biotechnol. 2010, 28, 868-873.
249. Kim, S. C., Sprung, R., Chen, Y., Xu, Y. et al., Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 2006, 23, 607-618.
250. Sefton, B. M., Trowbridge, I. S., Cooper, J. A., Scolnick, E. M., The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid. Cell 1982, 31, 465-474.
251. Schmidt, M. F., Schlesinger, M. J., Fatty acid binding to vesicular stomatitis virus glycoprotein: a new type of post-translational modification of the viral glycoprotein. Cell 1979, 17, 813-819.
252. Hang, H. C., Wilson, J. P., Charron, G., Bioorthogonal chemical reporters for analyzing protein lipidation and lipid trafficking. Acc. Chem. Res. 2011, 44, 699-708.
253. Sakurai, N., Utsumi, T., Posttranslational N-myristoylation is required for the anti-apoptotic activity of human tGelsolin, the C-terminal caspase cleavage product of human gelsolin. J. Biol. Chem. 2006, 281, 14288-14295.
254. Drisdel, R. C., Manzana, E., Green, W. N., The role of palmitoylation in functional expression of nicotinic alpha7 receptors. J. Neurosci. 2004, 24, 10502-10510.
255. Wall, S. B., Oh, J. Y., Mitchell, L., Laube, A. H. et al., Rac1 modification by an electrophilic 15-deoxy Delta(12, 14)-prostaglandin J2 analog. Redox Biol. 2015, 4, 346-354.
256. Witze, E. S., Old, W. M., Resing, K. A., Ahn, N. G., Mapping protein post-translational modifications with mass spectrometry. Nat. Methods 2007, 4, 798-806.
257. Ji, Y., Leymarie, N., Haeussler, D. J., Bachschmid, M. M. et al., Direct detection of S-palmitoylation by mass spectrometry. Anal. Chem. 2013, 85, 11952-11959.
258. Kwok, Y., Sung, W. C., Lin, A. L., Liu, H. H. et al., Rapid isolation and characterization of bacterial lipopeptides using liquid chromatography and mass spectrometry analysis. Proteomics 2011, 11, 2620-2627.
259. Ying, W., Perlman, D. H., Li, L., Theberge, R. et al., Highly efficient and selective enrichment of peptide subsets combining fluorous chemistry with reversed-phase chromatography. Rapid Commun. Mass Spectrom. 2009, 23, 4019-4030.
260. Gustafsson, M., Curstedt, T., Jornvall, H., Johansson, J., Reverse-phase HPLC of the hydrophobic pulmonary surfactant proteins: detection of a surfactant protein C isoform containing Nepsilon-palmitoyl-lysine. Biochem. J. 1997, 326(Pt 3), 799-806.
261. Bhawal, R. P., Sadananda, S. C., Bugarin, A., Laposa, B., Chowdhury, S. M., Mass spectrometry cleavable strategy for identification and differentiation of prenylated peptides. Anal. Chem. 2015, 87, 2178-2186.
262. Hoffman, M. D., Kast, J., Mass spectrometric characterization of lipid-modified peptides for the analysis of acylated proteins. J. Mass Spectrom. 2006, 41, 229-241.
263. Guan, Z., Identification and localization of the fatty acid modification in ghrelin by electron capture dissociation. J. Am. Soc. Mass Spectrom. 2002, 13, 1443-1447.
264. Kaczorowska, M. A., Cooper, H. J., Electron capture dissociation and collision induced dissociation of S-dipalmitoylated peptides. J. Am. Soc. Mass Spectrom. 2013, 24, 1224-1227.
265. Wotske, M., Wu, Y., Wolters, D. A., Liquid chromatographic analysis and mass spectrometric identification of farnesylated peptides. Anal. Chem. 2012, 84, 6848-6855.
266. Bordier, C., Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 1981, 256, 1604-1607.
267. Kjellstrom, S., Jensen, O. N., In situ liquid-liquid extraction as a sample preparation method for matrix-assisted laser desorption/ionization MS analysis of polypeptide mixtures. Anal. Chem. 2003, 75, 2362-2369.
268. Sachon, E., Nielsen, P. F., Jensen, O. N., Characterization of N-palmitoylated human growth hormone by in situ liquid-liquid extraction and MALDI tandem mass spectrometry. J. Mass Spectrom. 2007, 42, 724-734.
269. Wan, J., Roth, A. F., Bailey, A. O., Davis, N. G., Palmitoylated proteins: purification and identification. Nat. Protoc. 2007, 2, 1573-1584.
270. Wang, C., Weerapana, E., Blewett, M. M., Cravatt, B. F., A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles. Nat. Methods 2014, 11, 79-85.
271. Rostovtsev, V. V., Green, L. G., Fokin, V. V., Sharpless, K. B., A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. Angewandte Chemie 2002, 41, 2596-2599.
272. Das, D., Tnimov, Z., Nguyen, U. T., Thimmaiah, G. et al., Flexible and general synthesis of functionalized phosphoisoprenoids for the study of prenylation in vivo and in vitro. Chembiochem. 2012, 13, 674-683.
273. Hannoush, R. N., Sun, J., The chemical toolbox for monitoring protein fatty acylation and prenylation. Nat. Chem. Biol. 2010, 6, 498-506.
274. Windsor, K., Genaro-Mattos, T. C., Kim, H. Y., Liu, W. et al., Probing lipid-protein adduction with alkynyl surrogates: application to Smith-Lemli-Opitz syndrome. J. Lipid Res. 2013, 54, 2842-2850.
275. Saxon, E., Bertozzi, C. R., Cell surface engineering by a modified Staudinger reaction. Science 2000, 287, 2007-2010.
276. Heal, W. P., Wickramasinghe, S. R., Leatherbarrow, R. J., Tate, E. W., N-Myristoyl transferase-mediated protein labelling in vivo. Org. Biomol. Chem. 2008, 6, 2308-2315.
277. Charron, G., Zhang, M. M., Yount, J. S., Wilson, J. et al., Robust fluorescent detection of protein fatty-acylation with chemical reporters. J. Am. Chem. Soc. 2009, 131, 4967-4975.
278. Wilson, J. P., Raghavan, A. S., Yang, Y. Y., Charron, G., Hang, H. C., Proteomic analysis of fatty-acylated proteins in mammalian cells with chemical reporters reveals S-acylation of histone H3 variants. Mol. Cell. Proteomics 2011, 10, M110 001198.
279. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B. et al., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
280. Debets, M. F., van der Doelen, C. W., Rutjes, F. P., van Delft, F. L., Azide: a unique dipole for metal-free bioorthogonal ligations. Chembiochem. 2010, 11, 1168-1184.
281. Swaney, D. L., McAlister, G. C., Coon, J. J., Decision tree-driven tandem mass spectrometry for shotgun proteomics. Nat. Methods 2008, 5, 959-964.
282. Bailey, D. J., Rose, C. M., McAlister, G. C., Brumbaugh, J. et al., Instant spectral assignment for advanced decision tree-driven mass spectrometry. Proc. Natl. Acad. Sci. USA 2012, 109, 8411-8416.
283. Schuhmann, K., Almeida, R., Baumert, M., Herzog, R. et al., Shotgun lipidomics on a LTQ Orbitrap mass spectrometer by successive switching between acquisition polarity modes. J. Mass Spectrom. 2012, 47, 96-104.
284. Yuan, M., Breitkopf, S. B., Yang, X., Asara, J. M., A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat. Protoc. 2012, 7, 872-881.
285. Long, J., Tokhunts, R., Old, W. M., Houel, S. et al., Identification of a family of fatty-acid-speciated sonic hedgehog proteins, whose members display differential biological properties. Cell Rep. 2015, 10, 1280-1287.
286. Venne, A. S., Kollipara, L., Zahedi, R. P., The next level of complexity: crosstalk of posttranslational modifications. Proteomics 2014, 14, 513-524.
287. Hayashi, T., Rumbaugh, G., Huganir, R. L., Differential regulation of AMPA receptor subunit trafficking by palmitoylation of two distinct sites. Neuron 2005, 47, 709-723.
288. Hayashi, T., Thomas, G. M., Huganir, R. L., Dual palmitoylation of NR2 subunits regulates NMDA receptor trafficking. Neuron 2009, 64, 213-226.
289. Komekado, H., Yamamoto, H., Chiba, T., Kikuchi, A., Glycosylation and palmitoylation of Wnt-3a are coupled to produce an active form of Wnt-3a. Genes Cells 2007, 12, 521-534.
290. Kong, C., Lange, J. J., Samovski, D., Su, X. et al., Ubiquitination and degradation of the hominoid-specific oncoprotein TBC1D3 is regulated by protein palmitoylation. Biochem. Biophys. Res. Commun. 2013, 434, 388-393.
291. Yount, J. S., Karssemeijer, R. A., Hang, H. C., S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J. Biol. Chem. 2012, 287, 19631-19641.
292. Gallet, A., Rodriguez, R., Ruel, L., Therond, P. P., Cholesterol modification of hedgehog is required for trafficking and movement, revealing an asymmetric cellular response to hedgehog. Dev. Cell 2003, 4, 191-204.
293. Callejo, A., Torroja, C., Quijada, L., Guerrero, I., Hedgehog lipid modifications are required for Hedgehog stabilization in the extracellular matrix. Development 2006, 133, 471-483.
294. Nguyen, U. T., Cramer, J., Gomis, J., Reents, R. et al., Exploiting the substrate tolerance of farnesyltransferase for site-selective protein derivatization. Chembiochem. 2007, 8, 408-423.
295. Rose, M. W., Rose, N. D., Boggs, J., Lenevich, S. et al., Evaluation of geranylazide and farnesylazide diphosphate for incorporation of prenylazides into a CAAX box-containing peptide using protein farnesyltransferase. J. Pept. Res. 2005, 65, 529-537.
296. Rose, M. W., Xu, J., Kale, T. A., O'Doherty, G. et al., Enzymatic incorporation of orthogonally reactive prenylazide groups into peptides using geranylazide diphosphate via protein farnesyltransferase: implications for selective protein labeling. Biopolymers 2005, 80, 164-171.
297. Berry, A. F., Heal, W. P., Tarafder, A. K., Tolmachova, T. et al., Rapid multilabel detection of geranylgeranylated proteins by using bioorthogonal ligation chemistry. Chembiochem. 2010, 11, 771-773.
298. Jao, C. Y., Roth, M., Welti, R., Salic, A., Metabolic labeling and direct imaging of choline phospholipids in vivo. Proc. Natl. Acad. Sci. USA 2009, 106, 15332-15337.
299. Broncel, M., Serwa, R. A., Ciepla, P., Krause, E. et al., Multifunctional reagents for quantitative proteome-wide analysis of protein modification in human cells and dynamic profiling of protein lipidation during vertebrate development. Angewandte Chemie 2015, 54, 5948-5951.